BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Behzadi MA, Leyva-Grado VH, Namayandeh M, Ziyaeyan A, Feyznezhad R, Dorzaban H, Jamalidoust M, Ziyaeyan M. Seroprevalence of viral hepatitis A, B, C, D and E viruses in the Hormozgan province southern Iran. BMC Infect Dis 2019;19:1027. [PMID: 31795979 DOI: 10.1186/s12879-019-4661-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Bakhshipour A, Sargolzaie N, Rafaiee R. Status of Immunity Against the Hepatitis A Virus in Healthy Population: A Report From Southeastern Iran. Arch Clin Infect Dis 2021;16. [DOI: 10.5812/archcid.118869] [Reference Citation Analysis]
2 Azad AR, Zargar M, Zolfaghari MR, Mohammadbeigi A. The Prevalence of Hepatitis B and D Viruses and Evaluating YMDD Mutation in HBV-Suspected Patients in Qom Province, Iran. Jundishapur J Microbiol 2020;13. [DOI: 10.5812/jjm.100038] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Honarvar B, Zahedroozegar MH, Asmarian N, Zahedroozegar A, Saber K, B Lankarani K. Hepatitis A Chronic Immunity: A Population-Based Seroprevalence Study in Fars Province, Southern Iran. Hepat Mon 2022;21. [DOI: 10.5812/hepatmon-122238] [Reference Citation Analysis]
4 Heydari H, Majd A, Hamidi-fard M, Bahramali G, Aghasadeghi MR; Department of biology, North Tehran Branch, Islamic Azad University, Tehran, Iran, Department of Biology, North Tehran Branch, Islamic Azad University, Tehran, Iran, Hepatitis and AIDS Department, Pasteur Institute of Iran, Tehran, Iran & Viral Vaccine Research Center, Pasteur Institute of Iran, Tehran, Iran, Hepatitis and AIDS Department, Pasteur Institute of Iran, Tehran, Iran & Viral Vaccine Research Center, Pasteur Institute of Iran, Tehran, Iran, Hepatitis and AIDS Department, Pasteur Institute of Iran, Tehran, Iran & Viral Vaccine Research Center, Pasteur Institute of Iran, Tehran, Iran. Comparison of PCR with Serology for Detecting Acute Hepatitis A Virus Infection. JoMMID 2021;9:82-7. [DOI: 10.52547/jommid.9.2.82] [Reference Citation Analysis]
5 Qashqari FS. Seroprevalence of Hepatitis E Virus Infection in Middle Eastern Countries: A Systematic Review and Meta-Analysis. Medicina 2022;58:905. [DOI: 10.3390/medicina58070905] [Reference Citation Analysis]
6 Namayandeh M, Jamalidoust M, Heydari Marandi N, Aliabadi N, Ziyaeyan A, Pouladfar G, Ziyaeyan M. Hepatitis C virus genotypes in patients with chronic hepatitis C infection in southern Iran from 2016 to 2019. Microbiol Immunol 2020;64:762-7. [PMID: 32902892 DOI: 10.1111/1348-0421.12845] [Reference Citation Analysis]
7 Zangi M, Khodabandehloo M, Mohammadi S, Nouri B. The Seroprevalence of Hepatitis A Virus (HAV) Among Blood Donors Presenting to the Iranian Blood Transfusion Organization in Sanandaj, Iran. Hepat Mon 2020;20. [DOI: 10.5812/hepatmon.110357] [Reference Citation Analysis]
8 Hosseini SY, Joharinia N, Hosseini SA, Firoozi Ghahestani S, Ghojoghi R, Dorost K, Moghadami M, Gheshlaghi A, Jaberi O, Khoshbakht R, Sarvari J. Serosurvey of hepatitis A virus and E virus infection among municipal sweepers working in the largest city in the south of Iran. J Immunoassay Immunochem 2022;:1-9. [PMID: 35341459 DOI: 10.1080/15321819.2022.2052088] [Reference Citation Analysis]